Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients
- PMID: 18463433
- DOI: 10.1159/000130068
Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients
Abstract
Background: Natural killer (NK) cell activity is decreased in hemodialysis (HD) patients. Zeta-chain phosphorylation is an early event that follows the triggering of some NK cell-activating receptors. NK cell zeta-chain is downregulated in patients with cancer due to chronic inflammation. HD is also a chronic inflammatory state. NK cell zeta-chain expression in HD was evaluated.
Patients and methods: Thirty-three HD patients and 30 healthy volunteers were enrolled into the study. The CD3-CD16+ subpopulation was examined, since it corresponds to 90% of all NK cells and has the highest cytotoxicity.NK cell count and zeta-chain mean fluorescence intensity were evaluated with flow cytometry. The inflammatory markers C-reactive protein, IL-6 and tumor necrosis factor-alpha were measured with ELISA.
Results: The inflammatory markers were increased in HD patients. NK cell count did not differ between HD patients and healthy volunteers. NK cell zeta-chain mean fluorescence intensity was decreased in the patient group.
Conclusions: Chronic inflammation could be responsible for the NK cell zeta- chain downregulation in HD patients, contributing to the decreased NK cell activity.
(c) 2008 S. Karger AG, Basel
Comment in
-
Impaired NK cell function in ESRD patients.Blood Purif. 2008;26(4):315-6. doi: 10.1159/000130067. Epub 2008 May 8. Blood Purif. 2008. PMID: 18463432 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
